In conclusion, our study identifies EHMT2 as a cell-extrinsic driver of tumor growth that largely works via suppressing NK cell-mediated anti-tumor immunity, primarily through the repression of AZGP1 and activation of the TGF-β1. Here, EHMT2 is linked to neoplasm.